Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Routy

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Journal for Immunotherapy of Cancer|March 17, 2022
Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancerSafae Terrisse, Anne-Gaelle Goubet, Kousuke Ueda, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2024
The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effectsCarolin Ertl, Theresa Ruf, Dirk Mentzer, et al.
Science (New York, N.Y.)|November 7, 2015
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiotaMarie Vétizou, Jonathan M Pitt, Romain Daillère, et al.
Nature Medicine|February 4, 2022
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancerLisa Derosa, Bertrand Routy, Andrew Maltez Thomas, et al.
Nature Medicine|July 6, 2023
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trialBertrand Routy, John G Lenehan, Wilson H Miller, et al.
Nature Medicine|May 27, 2020
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancerMaria Paula Roberti, Satoru Yonekura, Connie P M Duong, et al.
EMBO Molecular Medicine|December 29, 2020
Immunodynamics of explanted human tumors for immuno-oncologyAgathe Dubuisson, Jean-Eudes Fahrner, Anne-Gaëlle Goubet, et al.
Cancer Discovery|December 21, 2021
Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to CarcinogenesisSatoru Yonekura, Safae Terrisse, Carolina Alves Costa Silva, et al.
Nature Medicine|January 28, 2026
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trialSreya Duttagupta, Meriem Messaoudene, Sebastian Hunter, et al.
Science (New York, N.Y.)|November 4, 2017
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumorsBertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Journal for Immunotherapy of Cancer|March 17, 2022
Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancerSafae Terrisse, Anne-Gaelle Goubet, Kousuke Ueda, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2024
The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effectsCarolin Ertl, Theresa Ruf, Dirk Mentzer, et al.
Science (New York, N.Y.)|November 7, 2015
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiotaMarie Vétizou, Jonathan M Pitt, Romain Daillère, et al.
Nature Medicine|February 4, 2022
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancerLisa Derosa, Bertrand Routy, Andrew Maltez Thomas, et al.
Nature Medicine|July 6, 2023
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trialBertrand Routy, John G Lenehan, Wilson H Miller, et al.
Nature Medicine|May 27, 2020
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancerMaria Paula Roberti, Satoru Yonekura, Connie P M Duong, et al.
EMBO Molecular Medicine|December 29, 2020
Immunodynamics of explanted human tumors for immuno-oncologyAgathe Dubuisson, Jean-Eudes Fahrner, Anne-Gaëlle Goubet, et al.
Cancer Discovery|December 21, 2021
Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to CarcinogenesisSatoru Yonekura, Safae Terrisse, Carolina Alves Costa Silva, et al.
Nature Medicine|January 28, 2026
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trialSreya Duttagupta, Meriem Messaoudene, Sebastian Hunter, et al.
Science (New York, N.Y.)|November 4, 2017
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumorsBertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, et al.
Pageof 13